文献检索，用中文搜 PubMed

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

核心技术专利：CN118964589B侵权必究

Helsby N A, Ward S A, Edwards G, Howells R E, Breckenridge A M

Department of Parasitology, Liverpool School of Tropical Medicine.

Br J Clin Pharmacol. 1990 Oct;30(4):593-8. doi: 10.1111/j.1365-2125.1990.tb03818.x.

Based on the ratio of drug to active metabolite excreted in urine approximately 3% of a healthy Caucasian population showed a reduced ability to convert proguanil to cycloguanil. 2. Pharmacokinetic analysis showed that this observation resulted from a reduced oral clearance of proguanil in these individuals (245, 534 and 552 ml min-1) compared with the rest of the population (858 +/- 482 ml min-1). 3. Peak plasma concentrations of active metabolite were significantly lower in these subjects (54.2, 26.8 and 51.7 ng ml-1) compared with the rest of the population (141 +/- 45.2 ng ml-1). 4. The observed variability may result from the polymorphic metabolism of proguanil in man.

根据尿中排泄的药物与活性代谢物的比例，约3%的健康白种人群将氯胍转化为环氯胍的能力降低。2. 药代动力学分析表明，这一观察结果是由于这些个体中氯胍的口服清除率降低（分别为245、534和552毫升/分钟），与其他人群（858±482毫升/分钟）相比。3. 这些受试者中活性代谢物的血浆峰值浓度显著低于其他人群（分别为54.2、26.8和51.7纳克/毫升），其他人群为（141±45.2纳克/毫升）。4. 观察到的变异性可能是由于人体中氯胍的多态性代谢所致。

Helsby N A, Ward S A, Edwards G, Howells R E, Breckenridge A M

Department of Parasitology, Liverpool School of Tropical Medicine.

Br J Clin Pharmacol. 1990 Oct;30(4):593-8. doi: 10.1111/j.1365-2125.1990.tb03818.x.

Based on the ratio of drug to active metabolite excreted in urine approximately 3% of a healthy Caucasian population showed a reduced ability to convert proguanil to cycloguanil. 2. Pharmacokinetic analysis showed that this observation resulted from a reduced oral clearance of proguanil in these individuals (245, 534 and 552 ml min-1) compared with the rest of the population (858 +/- 482 ml min-1). 3. Peak plasma concentrations of active metabolite were significantly lower in these subjects (54.2, 26.8 and 51.7 ng ml-1) compared with the rest of the population (141 +/- 45.2 ng ml-1). 4. The observed variability may result from the polymorphic metabolism of proguanil in man.

根据尿中排泄的药物与活性代谢物的比例，约3%的健康白种人群将氯胍转化为环氯胍的能力降低。2. 药代动力学分析表明，这一观察结果是由于这些个体中氯胍的口服清除率降低（分别为245、534和552毫升/分钟），与其他人群（858±482毫升/分钟）相比。3. 这些受试者中活性代谢物的血浆峰值浓度显著低于其他人群（分别为54.2、26.8和51.7纳克/毫升），其他人群为（141±45.2纳克/毫升）。4. 观察到的变异性可能是由于人体中氯胍的多态性代谢所致。